You are here: Home » PTI Stories » National » News
Business Standard

Novel test to diagnose 416 viruses from tropical regions

Press Trust of India  |  Washington 

In order to restrict the spread of diseases such as Zika and dengue, researchers have developed a platform that can analyse clinical samples from patients to diagnose infection by 416 viruses found in the world's tropical regions.

In addition to the pathogens, the platform detects others that as yet have been identified only sporadically but could become epidemics.



Examples include Mayaro, an alphavirus related to chikungunya that is transmitted by wild mosquitoes such as Haemagogus janthinomys.

"The number of patients with suspected dengue, Zika or chikungunya infection will increase when summer arrives," said Victor Hugo Aquino, professor at the University of Sao Paulo (USP) in Brazil.

"Conventional methods are frequently unable to confirm diagnosis of these diseases, so we don't know which viruses are circulating," said Aquino.

In his view, if a tool like this had been available when Zika began circulating in Brazil, it might have been possible to restrict its spread to the initial outbreak location.

"We took a long time to realise an epidemic was under way because no one was thinking of Zika at the time," he said.

"There are several other viruses that have not yet caused problems in humans but may do so one day," Aquino said.

"They are evolving all the time, and with the degradation of natural environments infectious agents once confined to natural niches could spread farther afield," added Aquino.

Although the platform is designed above all to detect pathogens transmitted by arthropods such as mosquitoes and ticks, it can also diagnose infectious agents transmitted by small mammals, like hantavirus.

Aquino explained that the selection encompasses all viruses occurring in tropical regions with DNA sequences deposited in GenBank, a public database maintained by the National Center for Biotechnology Information (NCBI), which is part of the US National Library of Medicine (NLM).

The platform consists of a DNA microarray slide with eight identical sub-arrays containing viral probes replicated at least three times to complete the array with 15,000 probes.

Each probe contains the sequences for 60 nucleotides that are complementary to the genomes of the viruses to be detected.

According to Aquino, the sequences were mounted on the basis of information from GenBank using bioinformatics.

"If a blood sample contains one of the 416 viruses included on the microchip, the pathogen's genome will bind with one of the probes to produce a marker that can be detected by a scanner," Aquino said.

The device that reads the results is the same as that used in microarray assays for the analysis of gene expression.

The validation tests do not point to cross-hybridisation, which produces a positive result for more than one infectious agent and hinders correct identification of single viruses.

The study was published in PLoS Neglected Tropical Diseases.

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

RECOMMENDED FOR YOU

Novel test to diagnose 416 viruses from tropical regions

In order to restrict the spread of diseases such as Zika and dengue, researchers have developed a platform that can analyse clinical samples from patients to diagnose infection by 416 viruses found in the world's tropical regions. In addition to the pathogens, the platform detects others that as yet have been identified only sporadically but could become epidemics. Examples include Mayaro, an alphavirus related to chikungunya that is transmitted by wild mosquitoes such as Haemagogus janthinomys. "The number of patients with suspected dengue, Zika or chikungunya infection will increase when summer arrives," said Victor Hugo Aquino, professor at the University of Sao Paulo (USP) in Brazil. "Conventional methods are frequently unable to confirm diagnosis of these diseases, so we don't know which viruses are circulating," said Aquino. In his view, if a tool like this had been available when Zika began circulating in Brazil, it might have been possible to restrict its spread to the ... In order to restrict the spread of diseases such as Zika and dengue, researchers have developed a platform that can analyse clinical samples from patients to diagnose infection by 416 viruses found in the world's tropical regions.

In addition to the pathogens, the platform detects others that as yet have been identified only sporadically but could become epidemics.

Examples include Mayaro, an alphavirus related to chikungunya that is transmitted by wild mosquitoes such as Haemagogus janthinomys.

"The number of patients with suspected dengue, Zika or chikungunya infection will increase when summer arrives," said Victor Hugo Aquino, professor at the University of Sao Paulo (USP) in Brazil.

"Conventional methods are frequently unable to confirm diagnosis of these diseases, so we don't know which viruses are circulating," said Aquino.

In his view, if a tool like this had been available when Zika began circulating in Brazil, it might have been possible to restrict its spread to the initial outbreak location.

"We took a long time to realise an epidemic was under way because no one was thinking of Zika at the time," he said.

"There are several other viruses that have not yet caused problems in humans but may do so one day," Aquino said.

"They are evolving all the time, and with the degradation of natural environments infectious agents once confined to natural niches could spread farther afield," added Aquino.

Although the platform is designed above all to detect pathogens transmitted by arthropods such as mosquitoes and ticks, it can also diagnose infectious agents transmitted by small mammals, like hantavirus.

Aquino explained that the selection encompasses all viruses occurring in tropical regions with DNA sequences deposited in GenBank, a public database maintained by the National Center for Biotechnology Information (NCBI), which is part of the US National Library of Medicine (NLM).

The platform consists of a DNA microarray slide with eight identical sub-arrays containing viral probes replicated at least three times to complete the array with 15,000 probes.

Each probe contains the sequences for 60 nucleotides that are complementary to the genomes of the viruses to be detected.

According to Aquino, the sequences were mounted on the basis of information from GenBank using bioinformatics.

"If a blood sample contains one of the 416 viruses included on the microchip, the pathogen's genome will bind with one of the probes to produce a marker that can be detected by a scanner," Aquino said.

The device that reads the results is the same as that used in microarray assays for the analysis of gene expression.

The validation tests do not point to cross-hybridisation, which produces a positive result for more than one infectious agent and hinders correct identification of single viruses.

The study was published in PLoS Neglected Tropical Diseases.

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

image
Business Standard
177 22

Novel test to diagnose 416 viruses from tropical regions

In order to restrict the spread of diseases such as Zika and dengue, researchers have developed a platform that can analyse clinical samples from patients to diagnose infection by 416 viruses found in the world's tropical regions.

In addition to the pathogens, the platform detects others that as yet have been identified only sporadically but could become epidemics.

Examples include Mayaro, an alphavirus related to chikungunya that is transmitted by wild mosquitoes such as Haemagogus janthinomys.

"The number of patients with suspected dengue, Zika or chikungunya infection will increase when summer arrives," said Victor Hugo Aquino, professor at the University of Sao Paulo (USP) in Brazil.

"Conventional methods are frequently unable to confirm diagnosis of these diseases, so we don't know which viruses are circulating," said Aquino.

In his view, if a tool like this had been available when Zika began circulating in Brazil, it might have been possible to restrict its spread to the initial outbreak location.

"We took a long time to realise an epidemic was under way because no one was thinking of Zika at the time," he said.

"There are several other viruses that have not yet caused problems in humans but may do so one day," Aquino said.

"They are evolving all the time, and with the degradation of natural environments infectious agents once confined to natural niches could spread farther afield," added Aquino.

Although the platform is designed above all to detect pathogens transmitted by arthropods such as mosquitoes and ticks, it can also diagnose infectious agents transmitted by small mammals, like hantavirus.

Aquino explained that the selection encompasses all viruses occurring in tropical regions with DNA sequences deposited in GenBank, a public database maintained by the National Center for Biotechnology Information (NCBI), which is part of the US National Library of Medicine (NLM).

The platform consists of a DNA microarray slide with eight identical sub-arrays containing viral probes replicated at least three times to complete the array with 15,000 probes.

Each probe contains the sequences for 60 nucleotides that are complementary to the genomes of the viruses to be detected.

According to Aquino, the sequences were mounted on the basis of information from GenBank using bioinformatics.

"If a blood sample contains one of the 416 viruses included on the microchip, the pathogen's genome will bind with one of the probes to produce a marker that can be detected by a scanner," Aquino said.

The device that reads the results is the same as that used in microarray assays for the analysis of gene expression.

The validation tests do not point to cross-hybridisation, which produces a positive result for more than one infectious agent and hinders correct identification of single viruses.

The study was published in PLoS Neglected Tropical Diseases.

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

image
Business Standard
177 22

Upgrade To Premium Services

Welcome User

Business Standard is happy to inform you of the launch of "Business Standard Premium Services"

As a premium subscriber you get an across device unfettered access to a range of services which include:

  • Access Exclusive content - articles, features & opinion pieces
  • Weekly Industry/Genre specific newsletters - Choose multiple industries/genres
  • Access to 17 plus years of content archives
  • Set Stock price alerts for your portfolio and watch list and get them delivered to your e-mail box
  • End of day news alerts on 5 companies (via email)
  • NEW: Get seamless access to WSJ.com at a great price. No additional sign-up required.
 

Premium Services

In Partnership with

 

Dear Guest,

 

Welcome to the premium services of Business Standard brought to you courtesy FIS.
Kindly visit the Manage my subscription page to discover the benefits of this programme.

Enjoy Reading!
Team Business Standard